References
- Abdel-Wahab M, Jose J, Richardt G. Transfemoral TAVI devices: design overview and clinical outcomes. EuroIntervention. 2015;11(W):W114–W118.
- Husser O, Kim WK, Pellegrini C, et al. Multicenter comparison of novel self-expanding versus balloon-expandable transcatheter heart valves. JACC Cardiovasc Interv [Internet]. 2017 cited 2021 Dec 19;10(20):2078–2087. Available from: https://pubmed.ncbi.nlm.nih.gov/29050625/
- Dvir D, Webb J, Brecker S, et al. Transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: results from the global valve-in-valve registry. Circulation [Internet]. 2012 cited 2020 Apr 2;126(19):2335–2344. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23052028
- Flameng W, Herregods MC, Vercalsteren M, et al. Prosthesis-patient mismatch predicts structural valve degeneration in bioprosthetic heart valves. Circulation [Internet]. 2010 cited 2022 Jan 2;121(19):2123–2129. Available from: https://pubmed.ncbi.nlm.nih.gov/20439787/
- Regazzoli D, Chiarito M, Cannata F, et al. Transcatheter self-expandable valve implantation for aortic stenosis in small aortic annuli: the TAVI-SMALL Registry. JACC Cardiovasc Interv. 2020;13(2):196–206.
- Hatoum H, Gooden SCM, Sathananthan J, et al. Neosinus and sinus flow after self-expanding and balloon-expandable transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2021;14(24):2657–2666.
- Capodanno D, Petronio AS, Prendergast B, et al. Standardized definitions of structural deterioration and valve failure in assessing long-term durability of transcatheter and surgical aortic bioprosthetic valves: a consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) endorsed by the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J [Internet]. 2017 cited 2022 May 14;38:3382–3390. [Internet]: http://academic.oup.com/eurheartj/article/38/45/3382/3980304
- Petronio AS, Sinning JM, Van Mieghem N, et al. Optimal implantation depth and adherence to guidelines on permanent pacing to improve the results of transcatheter aortic valve replacement with the medtronic corevalve system: the CoreValve prospective, international, post-market ADVANCE-II study. JACC Cardiovasc Interv [Internet]. 2015 cited 2020 Aug 13;8(6):837–846. Available from: https://pubmed.ncbi.nlm.nih.gov/25999108/
- Eggebrecht H, Vaquerizo B, Moris C, et al. Incidence and outcomes of emergent cardiac surgery during transfemoral transcatheter aortic valve implantation (TAVI): insights from the e uropean R egistry on e mergent C ardiac S urgery during TAVI (EuRECS-TAVI). Eur Heart J. 2018;39(8):676–684.
- Kim WK, Pellegrini C, Ludwig S, et al. Feasibility of coronary access in patients with acute coronary syndrome and previous TAVR. JACC Cardiovasc Interv Internet]. 2021 cited 2022 Jan 5;14(14):1578–1590. Available from: https://pubmed.ncbi.nlm.nih.gov/34294400/
- Tang GHL, Zaid S, Ahmad H, et al. Transcatheter valve neo-commissural overlap with coronary orifices after transcatheter aortic valve replacement. Circ Cardiovasc Interv. Internet]. 2018 cited 2022 Jan 3;11(10). Available from: https://pubmed.ncbi.nlm.nih.gov/30354640/
- Lederman RJ, Babaliaros VC, Rogers T, et al. Preventing Coronary obstruction during transcatheter aortic valve replacement: from computed tomography to BASILICA [Internet]. JACC Cardiovasc Interv Elsevier Inc 2019 [cited 2020 Aug 13]. 1197–1216. Available from: https://pubmed.ncbi.nlm.nih.gov/31272666/.
- Tang GHL, Zaid S, Fuchs A, et al. Alignment of Transcatheter Aortic-Valve Neo-Commissures (ALIGN TAVR): impact on final valve orientation and coronary artery overlap. JACC Cardiovasc Interv. 2020;13(9):1030–1042.
- De Marco F, Casenghi M, Spagnolo P, et al. A patient-specific algorithm to achieve commissural alignment with acurate Neo: the sextant technique. Catheter Cardiovasc Interv. 2021;98(6):E847–E854.
- Mangieri A, Montalto C, Pagnesi M, et al. TAVI and post procedural cardiac conduction abnormalities [Internet]. Front. Cardiovasc. Med. Frontiers Media S.A.; 2018 cited 2020 Aug 11]. Available from 2020 Aug 11: https://pubmed.ncbi.nlm.nih.gov/30018969/.
- Mendiz OA, Noč M, Fava CM, et al. Impact of Cusp-Overlap View for TAVR with Self-Expandable Valves on 30-Day Conduction Disturbances. J Interv Cardiol [Internet]. 2021 [cited 2022 Jan 3;2021. Available from: https://pubmed.ncbi.nlm.nih.gov/34007249/.
- Schäfer U, Kempfert J, Verheye S, et al. Safety and performance outcomes of a self-expanding transcatheter aortic heart valve: the BIOVALVE trials. JACC Cardiovasc Interv. 2020;13(2):157–166.
- Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J [Internet]. 2017 cited 2019 Apr 10;38:2739–2791. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28886619
- Dvir D, Webb JG, Bleiziffer S, et al. Transcatheter aortic valve implantation in failed bioprosthetic surgical valves. JAMA. J Am Med Assoc [Internet]. 2014 cited 2020 Apr 2;312(2):162–170. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25005653
- Waksman R, Craig PE, Torguson R, et al. Transcatheter aortic valve replacement in low-risk patients with symptomatic severe bicuspid aortic valve stenosis. JACC Cardiovasc Interv [Internet]. 2020;13(9):1019–1027. [cited 2020 Sep 12] . Available from: https://pubmed.ncbi.nlm.nih.gov/32381181/
- Yoon SH, Schmidt T, Bleiziffer S, et al. Transcatheter aortic valve replacement in pure native aortic valve regurgitation. J Am Coll Cardiol [Internet]. 2017;70(22):2752–2763.